In this regard, we have recently reported that patients with Early Arthritis (EA) and early Spondyloarthritis (SpA) who displayed low VIP serum levels at disease onset appeared to develop a greater burden of disease22,23. The gene discussed is VIP; the disease is arthritic joint disease.